Observational Study
doi: 10.1016/j.jaad.2019.12.070.
Epub 2020 Feb 20.
Real-world experience with mechlorethamine gel in patients with mycosis fungoides-cutaneous lymphoma: Preliminary findings from a prospective observational study
Affiliations
- PMID: 32089294
- DOI: 10.1016/j.jaad.2019.12.070
Item in Clipboard
Observational Study
Real-world experience with mechlorethamine gel in patients with mycosis fungoides-cutaneous lymphoma: Preliminary findings from a prospective observational study
J Am Acad Dermatol.
2020 Sep.
No abstract available
Similar articles
-
The PROVe Study: US Real-World Experience with Chlormethine/Mechlorethamine Gel in Combination with Other Therapies for Patients with Mycosis Fungoides Cutaneous T-Cell Lymphoma.Am J Clin Dermatol. 2021 May;22(3):407-414. doi: 10.1007/s40257-021-00591-x. Epub 2021 Mar 3. Am J Clin Dermatol. 2021. PMID: 33656660 Free PMC article.
-
Topical chemotherapy in cutaneous T-cell lymphoma: positive results of a randomized, controlled, multicenter trial testing the efficacy and safety of a novel mechlorethamine, 0.02%, gel in mycosis fungoides.JAMA Dermatol. 2013 Jan;149(1):25-32. doi: 10.1001/2013.jamadermatol.541. JAMA Dermatol. 2013. PMID: 23069814 Free PMC article. Clinical Trial.
-
Clinical potential of mechlorethamine gel for the topical treatment of mycosis fungoides-type cutaneous T-cell lymphoma: a review on current efficacy and safety data.Drug Des Devel Ther. 2018 Jan 31;12:241-254. doi: 10.2147/DDDT.S137106. eCollection 2018. Drug Des Devel Ther. 2018. PMID: 29440874 Free PMC article. Review.
-
In brief: mechlorethamine gel (Valchlor) for cutaneous T-Cell lymphoma.Med Lett Drugs Ther. 2015 Apr 27;57(1467):e66. Med Lett Drugs Ther. 2015. PMID: 25988964 Review. No abstract available.
-
A prospective study of cutaneous intolerance to topical mechlorethamine therapy in patients with cutaneous T-cell lymphomas. French Study Group of Cutaneous Lymphomas.Arch Dermatol. 1999 Nov;135(11):1349-53. doi: 10.1001/archderm.135.11.1349. Arch Dermatol. 1999. PMID: 10566833
Cited by
-
Effectiveness and tolerability of chlormethine gel for the management of mycosis fungoides: a multicenter real-life evaluation.Front Oncol. 2024 Jan 4;13:1298296. doi: 10.3389/fonc.2023.1298296. eCollection 2023. Front Oncol. 2024. PMID: 38239642 Free PMC article.
-
Mechlorethamine Hydrochloride Gel in the Treatment of Mycosis Fungoides-Type Cutaneous T-Cell Lymphoma (MF-CTCL): A Focus on Patient Selection and Special Considerations.Cancer Manag Res. 2022 Nov 22;14:3271-3279. doi: 10.2147/CMAR.S351420. eCollection 2022. Cancer Manag Res. 2022. PMID: 36444357 Free PMC article. Review.
-
Chlormethine Gel is Efficient and Safe in Mycosis Fungoides Skin Lesions.Acta Derm Venereol. 2022 Jun 9;102:adv00730. doi: 10.2340/actadv.v102.1095. Acta Derm Venereol. 2022. PMID: 35199177 Free PMC article.
-
Feasibility of Deriving Health State Utilities in Mycosis Fungoides Cutaneous T-Cell Lymphoma Using Mapping Algorithms.Pharmacoecon Open. 2022 Jul;6(4):595-603. doi: 10.1007/s41669-022-00326-6. Epub 2022 Feb 19. Pharmacoecon Open. 2022. PMID: 35182375 Free PMC article.
-
Increased Chlormethine-Induced DNA Double-Stranded Breaks in Malignant T Cells from Mycosis Fungoides Skin Lesions.JID Innov. 2021 Nov 25;2(1):100069. doi: 10.1016/j.xjidi.2021.100069. eCollection 2022 Jan. JID Innov. 2021. PMID: 34977846 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
